Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea

• Váldodahkkit: Ran-hui Cha (Dahkki), Shin Wook Kang (Dahkki), Cheol Whee Park (Dahkki), Dae Ryong Cha (Dahkki), Ki Young Na (Dahkki), Sung Gyun Kim (Dahkki), Sun Ae Yoon (Dahkki), Sejoong Kim (Dahkki), Sang Youb Han (Dahkki), Jung Hwan Park (Dahkki), Jae Hyun Chang (Dahkki), Chun Soo Lim (Dahkki), Yon Su Kim (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: The Korean Society of Nephrology, 2017-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: We investigated the long-term effect of AST-120, which has been proposed as a therapeutic option against renal disease progression, in patients with advanced chronic kidney disease (CKD). Methods: We performed post-hoc analysis with a per-protocol group of the K-STAR study (Kremezin stud...